Since BPC 157 does not cause gyno, the question is moot
Its compounding-pathway status shifted in April 2026 when the FDA removed it from Category 2 of the 503A bulk substances list, though this is a compounding determination, not an approval
K.MaloneyB.ZawiaN
As a close structural relative of GHK-Cu (Gly-His-Lys), AHK-Cu shares the copper-chelating tripeptide architecture but exhibits a distinct biological activity profile studied particularly in the contexts of hair follicle biology, angiogenesis, and skin extracellular matrix research
Results vary, but many patients notice increased energy and improved metabolism within a few weeks
Mounjaro is administered as a once-weekly subcutaneous injection, which may lead to this misconception, as vitamin B12 deficiency is also commonly treated with injections